theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Hematologic Malignancies

Thrombosis   

Questions discussed in this category


What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
New data suggests monoclonal gammopathies can be associated with thrombotic events. Is your practice changing to include monoclonal gammopathy evaluat...
1 Answer available

In a patient with history of recurrent VTE despite anticoagulation, would you consider lenalidomide as part of your initial myeloma regimen?
2 Answers available
2300822170


Papers discussed in this category


Platelets, 2023 Oct 11
Multiple myeloma and its treatment contribute to increased platelet reactivity.

Blood, 2011 Aug 11
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide.

Related Topics in Hematologic Malignancies

  • Breast Cancer
  • Head and Neck Cancers
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers
  • Pediatric Hematology/Oncology
  • Sarcoma

Copyright © 2025 theMednet
All Rights Reserved.